The Microbiome

The Oral-Gut Axis: How Your Mouth Microbiome Affects Your Stomach

April 23, 202610 min readBy GLP1Gut Team
oral microbiomeoral-gut axisperiodontal diseasePPIsgut health

📋TL;DR: Your mouth is home to over 700 bacterial species, and an increasing body of research shows that these oral bacteria do not stay in the mouth. They travel to the gut, and in certain conditions, they establish themselves there and contribute to disease. PPI use, which reduces the stomach acid that normally kills swallowed oral bacteria, is associated with gut microbiomes that resemble oral communities. Periodontal disease organisms like Fusobacterium nucleatum and Porphyromonas gingivalis have been found in inflamed gut tissue of patients with IBD and colorectal cancer. Oral health is an underappreciated factor in digestive health, and the connection between these two systems deserves more clinical attention.

What We Know

  • The oral cavity hosts over 700 bacterial species, making it the second most diverse microbial site in the human body after the gut (Dewhirst et al., 2010).
  • Oral bacteria are detectable in the gut microbiome of healthy individuals, but their abundance is significantly higher in people with certain GI conditions (Schmidt et al., 2019).
  • PPI use is associated with increased oral bacterial abundance in the gut, consistent with reduced gastric acid barrier function (Imhann et al., 2016).
  • Fusobacterium nucleatum, an oral pathobiont, has been consistently found enriched in colorectal cancer tissue and is associated with poorer prognosis (Castellarin et al., 2012).
  • Porphyromonas gingivalis, the primary pathogen in severe periodontal disease, has been detected in the gut and linked to increased intestinal permeability in animal models (Arimatsu et al., 2014).
  • Patients with inflammatory bowel disease show higher levels of oral bacteria in their gut microbiome compared to healthy controls (Atarashi et al., 2017).

What We Don't Know

  • Whether oral bacteria directly cause gut disease or whether they are markers of an already disrupted gut environment that has become more permissive to colonization.
  • The exact mechanisms by which oral bacteria survive transit through the GI tract and establish themselves in the gut, beyond reduced stomach acid.
  • Whether treating periodontal disease improves gut health outcomes, or whether the association is correlative.
  • How much oral bacterial translocation occurs through saliva swallowing versus the bloodstream (hematogenous route).
  • Whether specific oral hygiene practices can meaningfully reduce oral bacterial abundance in the gut.

When people think about gut health, they rarely think about their mouth. The oral cavity and the intestines seem like separate worlds, each with their own concerns. You go to the dentist for your teeth and to the gastroenterologist for your stomach. But the more researchers study the microbiome, the clearer it becomes that these two systems are connected in ways that have real clinical implications. Your mouth is home to one of the most complex microbial communities in your body, and those bacteria do not simply stay put. You swallow roughly a trillion bacteria per day along with your saliva, and whether those bacteria survive the trip to your gut depends on factors that are surprisingly within your control.

The oral microbiome: the second most complex microbial community in your body

The oral cavity harbors over 700 identified bacterial species, making it second only to the gut in microbial diversity (Dewhirst et al., 2010). These organisms live on your teeth, gums, tongue, cheeks, and in the crevices between your teeth and gum line. In a healthy mouth, this community exists in a relatively stable balance, with Streptococcus, Neisseria, Haemophilus, and Veillonella species forming the dominant groups.

The oral microbiome has its own ecosystem dynamics. When oral hygiene is poor, the balance shifts. Pathogenic species like Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola gain a foothold, particularly in the gingival crevices where they can form biofilms below the gum line. This is what periodontitis is: a chronic inflammatory condition driven by a dysbiotic oral microbiome. It affects roughly 42% of U.S. adults over 30, with about 7.8% having severe forms (Eke et al., 2015). It is extremely common, and its connection to systemic health, including gut health, is only recently being appreciated.

How oral bacteria reach the gut

The primary route of oral bacteria entering the gut is straightforward: you swallow them. The average person produces and swallows between 1 and 1.5 liters of saliva per day, and that saliva is loaded with microorganisms. One milliliter of saliva contains roughly 100 million bacteria. Over the course of a day, you are sending enormous numbers of oral bacteria downstream toward your stomach and intestines.

Under normal conditions, most of these bacteria are killed by gastric acid. The stomach maintains a pH of about 1.5 to 3.5, which is hostile to the vast majority of oral organisms. This acid barrier is one of the stomach's most important defensive functions, and it is the reason why the healthy gut microbiome looks very different from the oral microbiome despite the constant bacterial transit between them.

But there is a second route that researchers are increasingly investigating: the hematogenous (bloodstream) route. During routine activities like chewing, brushing, and flossing, and especially during periodontal disease, oral bacteria can enter the bloodstream through inflamed or damaged gum tissue. Once in circulation, they can reach the intestines via the blood supply. This route bypasses the stomach acid barrier entirely, which may explain why certain oral pathogens are found in the gut even in people with normal acid production.

PPIs and the oral-gut connection

Proton pump inhibitors reduce stomach acid production by up to 99%, and this has a dramatic effect on which swallowed bacteria survive the trip to the gut. Multiple large-scale studies have shown that PPI users have gut microbiomes that look more like oral microbiomes than non-users' guts do. Imhann et al. (2016) found that PPI use was associated with significant increases in typically oral genera, including Streptococcus, Veillonella, and Rothia, in the gut microbiome.

A study by Freedberg et al. (2015) demonstrated that even a short course of PPIs (just two weeks) was enough to shift the gut microbiome toward increased oral-type bacteria. Jackson et al. (2016) found that among all drug classes they examined, PPIs had the largest effect size on the gut microbiome, larger even than antibiotics in chronic use settings.

The clinical relevance of this shift is still being worked out. PPI use is associated with increased risk of enteric infections, including C. difficile, Salmonella, and Campylobacter. Whether this increased risk is due to the specific oral bacteria colonizing the gut, the general reduction in microbial resistance to pathogens, or the loss of acid itself as a direct antimicrobial barrier is not fully resolved. It is likely a combination of all three.

â„šī¸If you are on a long-term PPI, this does not mean you need to stop it. But it does mean that your gut's microbial gatekeeper (stomach acid) is functioning at a fraction of its normal capacity, and maintaining good oral hygiene may be more important for your gut health than you might think.

Periodontal bacteria in the inflamed gut

Some of the most compelling evidence for the oral-gut axis comes from studies finding oral pathogens in diseased intestinal tissue. Fusobacterium nucleatum, a bacterium primarily associated with the oral cavity and periodontal disease, has been found enriched in colorectal cancer tissue in multiple independent studies. Castellarin et al. (2012) first reported this finding, and it has been replicated extensively. The presence of F. nucleatum in tumors is associated with a worse prognosis, and experimental work has shown that F. nucleatum can promote tumor growth by modulating the immune microenvironment and activating oncogenic signaling pathways (Rubinstein et al., 2013).

Porphyromonas gingivalis, the keystone pathogen in severe periodontitis, has also been implicated in gut disease. Arimatsu et al. (2014) showed that oral administration of P. gingivalis in mice altered the gut microbiome, increased intestinal permeability, and elevated systemic inflammation. While mouse studies do not directly translate to humans, they provide a mechanistic foundation for the associations seen in epidemiological studies linking periodontal disease to gut inflammation.

In inflammatory bowel disease, a landmark 2017 study by Atarashi et al. demonstrated that certain oral bacteria, when they reach the gut, can activate immune cells and promote inflammation. They found that strains of Klebsiella isolated from the saliva of Crohn's disease patients could colonize the mouse gut and drive colitis in genetically susceptible animals. This suggested a direct pathway from oral microbiome dysbiosis to gut inflammation, at least in the context of genetic susceptibility.

Oral health as an overlooked component of digestive health

Dental care and gastroenterology exist in separate clinical silos. Your dentist does not ask about your bowel habits, and your GI doctor does not ask about your gum health. But the emerging research on the oral-gut axis suggests these conversations should be happening. Periodontal disease is treatable and, in early stages, reversible. If oral dysbiosis contributes to gut inflammation, then dental care is potentially a GI intervention that no one is prescribing.

To be clear, the evidence is still primarily observational and mechanistic. We do not yet have randomized controlled trials showing that treating periodontal disease improves IBD outcomes or reduces colorectal cancer risk. These would be difficult studies to design and conduct. But the associations are strong enough and biologically plausible enough that several research groups are pursuing this question. In the meantime, maintaining good oral hygiene is low-risk, low-cost, and has established benefits for cardiovascular health and glycemic control in diabetes, independent of any gut effects.

  • Regular brushing and flossing reduce the pathogenic bacterial load in the mouth, which reduces the number of harmful organisms swallowed daily.
  • Treating periodontal disease reduces systemic inflammation markers like C-reactive protein and IL-6, which also play roles in gut inflammation.
  • Avoiding tobacco products and excessive alcohol, both of which disrupt the oral microbiome, may have downstream benefits for gut health.
  • Regular dental check-ups catch periodontal disease early, when it is most treatable and before chronic inflammatory damage accumulates.
  • If you are on a PPI, good oral hygiene may be particularly important because you have lost the acid barrier that normally prevents oral bacteria from colonizing the gut.

Tracking symptoms at the intersection of oral and gut health

If you are dealing with both periodontal disease and GI symptoms, or if you are on medications that reduce stomach acid, tracking your symptoms alongside your oral health practices may reveal patterns you would not otherwise notice. GLP1Gut can help you log GI symptoms, medication use, and dietary habits so you have a clear picture to share with both your dentist and your gastroenterologist. Building a data record over weeks and months can help identify whether flares in gut symptoms coincide with dental issues or medication changes.

The bottom line on the oral-gut axis

The connection between the oral and gut microbiomes is one of the more genuinely exciting areas of microbiome research. The evidence that oral bacteria can colonize the gut, especially when the acid barrier is compromised, is well established. The evidence that specific oral pathogens contribute to gut inflammation and colorectal cancer is growing and biologically plausible. And the recognition that oral health is an overlooked factor in digestive health is slowly gaining traction in both dental and gastroenterology communities.

What we still need is interventional data. Can treating periodontal disease reduce the risk of gut inflammation? Can improving oral hygiene change the gut microbiome in clinically meaningful ways? Does dental care belong in the treatment plan for patients with IBD or a history of colorectal polyps? These are testable questions, and researchers are beginning to pursue them. In the meantime, taking care of your mouth is unlikely to hurt your gut and might genuinely help it. That is a reasonable enough basis for action while we wait for the definitive trials.

Can mouthwash affect my gut microbiome?

Possibly. Chlorhexidine mouthwash, the most studied antiseptic rinse, has been shown to alter the oral microbiome significantly and can reduce nitric oxide production by killing nitrate-reducing oral bacteria. Whether these changes cascade to the gut microbiome has not been well studied, but the theoretical pathway exists through reduced bacterial load in swallowed saliva.

Does stomach acid actually kill most oral bacteria?

Yes. At a pH of 1.5 to 3.5, gastric acid is lethal to the vast majority of oral bacteria. This is why the healthy gut microbiome looks so different from the oral microbiome despite constant exposure through swallowed saliva. When PPIs raise the stomach pH to 4 to 7, many more oral organisms survive the transit.

Should I tell my gastroenterologist about my dental health?

It is worth mentioning, especially if you have active periodontal disease and concurrent GI symptoms. Most GI doctors are not currently asking about oral health, but awareness of the oral-gut axis is increasing. Providing a complete picture of your health helps your providers make better decisions.

Is Fusobacterium nucleatum a cause of colorectal cancer?

F. nucleatum is consistently found enriched in colorectal tumors and is associated with worse outcomes, but whether it plays a causal role or is an opportunistic colonizer of tumor tissue is still debated. Experimental evidence shows it can promote tumor growth in animal models, but a definitive causal role in human cancer has not been established.

Key Takeaways

  1. 1The mouth and gut are connected, not isolated. Oral bacteria travel to the gut primarily through swallowed saliva, and you swallow roughly 1 to 1.5 liters of saliva per day.
  2. 2Stomach acid serves as a critical barrier against oral bacteria colonizing the gut. When this barrier is reduced by PPIs, oral bacteria appear in higher abundance in the intestinal microbiome.
  3. 3Periodontal disease organisms have been found in inflamed gut tissue, colorectal tumors, and the microbiomes of IBD patients, suggesting oral health may influence GI disease risk.
  4. 4Good oral hygiene is probably a component of gut health, though clinical trials demonstrating a direct benefit of dental care on GI outcomes are still needed.
  5. 5This is an emerging area of research with strong observational evidence but limited interventional data so far.

Sources & References

  1. 1.The Human Oral Microbiome - Dewhirst FE, Chen T, Izard J, et al., Journal of Bacteriology (2010)
  2. 2.Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma - Castellarin M, Warren RL, Freeman JD, et al., Genome Research (2012)
  3. 3.Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation - Atarashi K, Suda W, Luo C, et al., Science (2017)
  4. 4.Oral Porphyromonas gingivalis translocates to the liver and regulates hepatic glycogen synthesis through the Akt/GSK-3beta signaling pathway - Arimatsu K, Yamada H, Miyazawa H, et al., PLoS ONE (2014)
  5. 5.Proton pump inhibitors affect the gut microbiome - Imhann F, Bonder MJ, Vich Vila A, et al., Gut (2016)
  6. 6.Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment - Rubinstein MR, Wang X, Liu W, et al., Cell Host & Microbe (2013)
  7. 7.Prevalence of periodontitis in adults in the United States: 2009 and 2010 - Eke PI, Dye BA, Wei L, et al., Journal of Dental Research (2015)
  8. 8.Extensive transmission of microbes along the gastrointestinal tract - Schmidt TSB, Hayward MR, Coelho LP, et al., eLife (2019)
  9. 9.Proton pump inhibitors alter the composition of the gut microbiota - Jackson MA, Goodrich JK, Maxan ME, et al., Gut (2016)

Medical Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Always consult with a qualified healthcare professional before making changes to your diet, medications, or health regimen. GLP1Gut is a tracking tool, not a medical device.

Figure Out What's Actually Triggering You

An AI-powered meal and symptom tracker that connects what you eat to how you feel, built specifically for people on GLP-1 medications experiencing digestive side effects.